Of the 38 PBC patients 32 (84%) had anti-mAChR3 and anti-M2/PDC-E2 antibodies (of the IgG- and/or IgM-type) in parallel (Table 4). This evidence concerns the gene CD40LG and primary biliary cholangitis.